MODERATOR
:
SPEAKER
(S):
Edward Wong, MD, Associate Director of Transfusion Medicine, Children's National Medical Center
Challenges And Use of Therapeutic Apheresis In The Treatment Of Pediatric FSGS
David Friedman, MD, Associate Medical Director of Transfusion Service, Children's Hospital of Philadelphia
Treatment of PANDAS Using Therapeutic Apheresis, Indications, Challenges and Outcomes,
Dr. Kelley Capocelli, MD, Medical Director of Transfusion Medicine Services, Children's Hospital Colorado
The Use of ECP for the Treatment of Pediatric APS and PICC Lines for Acess
Description
The program builds on the previous year's AABB program and is designed to describe the use of therapeutic apheresis/photophoresis in a pediatric setting with diseases and disease processes that are more rare and challenging to treat. The program also aims to address access issues and the successful use of PICC lines in one pediatric center.
-
Define the challenges and use of therapeutic apheresis in the treatment of pediatric FSGS.
-
Describe the experimental use of ECP in pediatric APS patients and the use of PICC lines for access.
-
Describe the use of therapeutic apheresis in the treatment of a pediatric neuropsychiatric disease, PANDAS.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.